Close

Intuitive Surgical (ISRG), Fosun Pharma Establish JV Targeting Lung Cancer Diagnostic and Therapeutic Tools in China

Go back to Intuitive Surgical (ISRG), Fosun Pharma Establish JV Targeting Lung Cancer Diagnostic and Therapeutic Tools in China

Intuitive Surgical and Fosun Pharma Establish Joint Venture to Research, Develop, Manufacture and Sell Lung Cancer Diagnostic and Therapeutic Tools in China

September 29, 2016 8:55 AM EDT

SUNNYVALE, Calif., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (NASDAQ: ISRG) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Fosun Pharma (600196.SH), (HKSE: 2196), today announced a joint venture to research, develop, manufacture and sell innovative, robotic-assisted catheter-based medical devices.

The joint venture between Intuitive Surgical, the global leader in robotic-assisted minimally invasive surgery, and Fosun Pharma, a leading healthcare group strategically comprising the complete value chain, will initially produce products targeting early diagnosis and cost-effective treatment of lung cancer, one of the most commonly diagnosed forms... More